Other Clinical Trial - Telavancin for Treatment of Uncomplicated

See also
Status	Clinical Trial	Phase
Completed	`NCT01412801` - Magnitude of the Antibody Response to and Safety of a GBS Trivalent Vaccine in HIV Positive and HIV Negative Pregnant Women and Their Offsprings	Phase 2
Terminated	`NCT00108433` - Linezolid in the Treatment of Hemodialysis Patients With Catheter-Related Gram-Positive Bloodstream Infections	Phase 3
Completed	`NCT00501150` - Oral Antibiotic Treatment at Home Instead of Intravenous Treatment in Hospital for Resistant Gram Positive Infections	N/A
Not yet recruiting	`NCT06444802` - Model-informed Precision Dosing for Linezolid	Phase 3
Terminated	`NCT00529282` - A Study of Ceftobiprole in Patients With Fever and Neutropenia.	Phase 3
Completed	`NCT00079976` - Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)	Phase 3
Terminated	`NCT00835783` - Validation Study of Combined Positron Emission Tomography/Computer Tomography to Diagnose Infection and Inflammation	N/A
Completed	`NCT00081744` - Study Comparing Tigecycline to Imipenem/Cilastatin in Complicated Intra-Abdominal Infections in Hospitalized Subjects	Phase 3
Completed	`NCT03747497` - Contezolid Acefosamil Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection	Phase 2
Active, not recruiting	`NCT04911270` - Clinical Decision Support Tool for Vancomycin Dosing in Children	N/A
Completed	`NCT02750761` - A Study of Oral and Intravenous (IV) Tedizolid Phosphate in Hospitalized Participants, Ages 2 to <12 Years, With Confirmed or Suspected Bacterial Infection (MK-1986-013)	Phase 1
Completed	`NCT00406198` - Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis	Phase 4
Completed	`NCT03560440` - Evaluation of the Dosing Regimen of Vancomycin in Pediatric Patients
Completed	`NCT00147511` - Time To Efficacy and Onset Of Action Of Linezolid	Phase 4
Terminated	`NCT00240747` - Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients	Phase 3
Not yet recruiting	`NCT04917380` - The Clinical Character，Risk and Prognosis of Post-neurosurgical Intracranial Infection With Different Pathogens.
Completed	`NCT00736554` - What is the Prevalence of Methicillin-Resistant Staphylococcus Aureus in Skin and Soft Tissue Infections Presenting to the Emergency Departments of a Canadian Academic Health Care Center?	N/A
Completed	`NCT03361163` - Controlled Human Infection for Vaccination Against Streptococcus Pyogenes	Phase 1
Completed	`NCT00167960` - Study Evaluating Vancomycin-Resistant Enterococci in a Hematology Unit	Phase 4
Completed	`NCT00874367` - Early-Onset Sepsis Surveillance Study	N/A

NCT number	NCT00062647
Study type	Interventional
Source	Cumberland Pharmaceuticals
Contact
Status	Completed
Phase	Phase 2
Start date	August 2003
Completion date	August 2006

Telavancin for Treatment of Uncomplicated Staphylococcus Aureus Bacteremia — ASSURE

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms